357 related articles for article (PubMed ID: 30367972)
1. Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review.
Issaka RB; Avila P; Whitaker E; Bent S; Somsouk M
Prev Med; 2019 Jan; 118():113-121. PubMed ID: 30367972
[TBL] [Abstract][Full Text] [Related]
2. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
[TBL] [Abstract][Full Text] [Related]
4. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
5. Implementing Mailed Colorectal Cancer Fecal Screening Tests in Real-World Primary Care Settings: Promising Implementation Practices and Opportunities for Improvement.
Hohl SD; Maxwell AE; Sharma KP; Sun J; Vu TT; DeGroff A; Escoffery C; Schlueter D; Hannon PA
Prev Sci; 2024 Apr; 25(Suppl 1):124-135. PubMed ID: 36952143
[TBL] [Abstract][Full Text] [Related]
6. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
7. Effective strategies for Fecal Immunochemical Tests (FIT) programs to improve colorectal cancer screening uptake among populations with limited access to the healthcare system: a rapid review.
Belon AP; McKenzie E; Teare G; Nykiforuk CIJ; Nieuwendyk L; Kim MO; Lee B; Adhikari K
BMC Health Serv Res; 2024 Jan; 24(1):128. PubMed ID: 38263112
[TBL] [Abstract][Full Text] [Related]
8. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
[TBL] [Abstract][Full Text] [Related]
9. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees.
Davis MM; Nambiar S; Mayorga ME; Sullivan E; Hicklin K; O'Leary MC; Dillon K; Hassmiller Lich K; Gu Y; Lind BK; Wheeler SB
Prev Med; 2019 Dec; 129S():105836. PubMed ID: 31635848
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?
Davis MM; Freeman M; Shannon J; Coronado GD; Stange KC; Guise JM; Wheeler SB; Buckley DI
BMC Cancer; 2018 Jan; 18(1):40. PubMed ID: 29304835
[TBL] [Abstract][Full Text] [Related]
11. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
[TBL] [Abstract][Full Text] [Related]
13. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
[TBL] [Abstract][Full Text] [Related]
14. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
[TBL] [Abstract][Full Text] [Related]
15. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.
Gupta S; Coronado GD; Argenbright K; Brenner AT; Castañeda SF; Dominitz JA; Green B; Issaka RB; Levin TR; Reuland DS; Richardson LC; Robertson DJ; Singal AG; Pignone M
CA Cancer J Clin; 2020 Jul; 70(4):283-298. PubMed ID: 32583884
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
17. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y
Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490
[TBL] [Abstract][Full Text] [Related]
19. Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.
Scott RE; Chang P; Kluz N; Baykal-Caglar E; Agrawal D; Pignone M
J Gen Intern Med; 2023 May; 38(7):1631-1637. PubMed ID: 36456842
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis.
Zhong GC; Sun WP; Wan L; Hu JJ; Hao FB
Gastrointest Endosc; 2020 Mar; 91(3):684-697.e15. PubMed ID: 31790657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
